Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: A 3,4-dihdroxy-6-[F-18] fluorophenyl-L-alanine PET study
Erstveröffentlichung
2008
Beitrag zu einer Konferenz
Published in
NeuroImage ; 41 (2008), 3. - S. 718-727. - ISSN 1053-8119
Link to publication
https://dx.doi.org/10.1016/j.neuroimage.2008.02.025Institutions
UKU. Klinik für NeurologieUKU. Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie
UKU. Klinik für diagnostische und interventionelle Radiologie
UKU. Klinik für Nuklearmedizin
Conference
53rd Annual Meeting of the American-Academy-of-Child-and-Adolescent-Psychiatry, 2006-11-24 - 2006-11-29, San Diego, CA
Fachliche Einordnung
[Freie Tags]: ADHD, FDOPA PET, methylphenidate, dopamine metabolism, SPM2, positron emission tomography, brain transfer constants, substance use disorders, time uptake data, deficit/hyperactivity disorder, parkinsons-disease, oral methylphenidate, graphical evaluation, f-18-dopa pet, transporterDDC 150 / Psychology